Driehaus Capital Management’s AstraZeneca AZN Stock Holding History

Driehaus Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$752K	Hold	3,967	–	–	﹤0.01%	337
2026 Q1	$782K	Sell	3,967 -920	-19%	-$177K	0.01%	324
2025 Q4	$899K	Buy	4,887 +1,878	+62%	+$329K	0.01%	356
2025 Q3	$462K	Sell	3,009 -2,908	-49%	-$440K	﹤0.01%	407
2025 Q2	$827K	Hold	5,917	–	–	0.01%	364
2025 Q1	$870K	Hold	5,917	–	–	0.01%	351
2024 Q4	$775K	Buy	5,917 +946	+19%	+$132K	0.01%	339
2024 Q3	$775K	Sell	4,971 -1,607	-24%	-$259K	0.01%	326
2024 Q2	$1.03M	Buy	6,578 +2,689	+69%	+$405K	0.01%	308
2024 Q1	$527K	Buy	3,889 +1,620	+71%	+$215K	0.01%	344
2023 Q4	$306K	Sell	2,269 -2,622	-54%	-$341K	﹤0.01%	355
2023 Q3	$662K	Buy	4,891 +2,231	+84%	+$305K	0.01%	338
2023 Q2	$381K	Buy	+2,660	New	+$391K	﹤0.01%	350
2016 Q1	–	Sell	-100,146	Closed	-$6.8M	–	547
2015 Q4	$6.8M	Buy	+100,146	New	+$6.57M	0.23%	99
2015 Q1	–	Sell	-17,174	Closed	-$1.21M	–	497
2014 Q4	$1.21M	Buy	+17,174	New	+$1.23M	0.05%	380

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Driehaus Capital Management's AZN Position: Q2 2026 in Review

Driehaus Capital Management held its AstraZeneca (AZN) position steady in Q2 2026 at 3,967 shares worth $752K. The position accounts for ﹤0.01% of the portfolio, ranked #337.

Driehaus Capital Management first reported a position in AZN in Q4 2014 and has held it in 15 quarters since. The position peaked at $6.8M in Q4 2015. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Driehaus Capital Management held 3,967 shares of AstraZeneca worth $752K as of Q2 2026.
Driehaus Capital Management left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up ﹤0.01% of Driehaus Capital Management's portfolio in Q2 2026, its #337 holding.
Driehaus Capital Management first reported a position in AstraZeneca in Q4 2014 and has held it in 15 quarters since.
Driehaus Capital Management's AstraZeneca position peaked at $6.8M in Q4 2015.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Driehaus Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.